EU-OPENCREEN is a European Research Infrastructure Consortium (ERIC) founded in April 2018 by seven European Countries: the Czech Republic, Finland, Germany, Latvia, Norway, Poland and Spain. Denmark became a full member in the beginning of 2019 and Portugal joined in the beginning of 2022. More countries are preparing their participation.
EU-OPENSCREEN offers researchers from Europe and around the world open access to a uniquely broad range of high technologies and tools for the systematic screening of chemical substances for their biological effects. EU-OPENSCREEN integrates high-capacity screening platforms throughout Europe, which jointly use a rationally selected compound collection with more than 100.000 commercial and proprietary compounds collected from European chemists. For more information on our compound collections please see here.
EU-OPENSCREEN will collaboratively develop novel molecular tool compounds with external users from various disciplines of the life sciences. EU-OPENSCREEN has no bias towards target families, biological topics or models. EU-OPENSCREEN explicitly advocates wide-ranging projects that will enhance cross-fertilization between disciplines.
EU-OPENSCREEN supports all stages of a tool development project, including assay adaptation, high-throughput screening, and chemical optimisation of the ‘hit’ compounds. All generated tool compounds and data are made available in an open access database.
The EU-OPENSCREEN ERIC Central Office is located on Campus Buch in Berlin, Germany.